Skip to content
Sunday 16 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,750.11
-0.21%
DAX
26,440.31
+0.53%
CAC 40
8,636.80
-0.16%
STOXX 50
6,539.59
-0.09%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Friday 05 October 2018 12:09 am  |  Updated:  Tuesday 21 May 2019 4:24 pm

City Moves for 5 October 2018 – who’s switching jobs at Hikma Pharmaceuticals, Evestment, Nucleus and Morning Wire?

By: Francesca Washtell

Add as a preferred source on Google

NULL

Today's City Moves covers pharma, investment, IT and City Moves. Take a look at these movers and shakers:

Hikma Pharmaceuticals

Hikma Pharmaceuticals has appointed Sagar Patel to a newly created London-based role as the European commercial head for its injectables business. Sagar joins Hikma at a time of organisational change to boost the group’s senior leadership capabilities and expand its reach across Europe. Having worked for many years in pharmaceutical and FMCG businesses, he brings a breadth of commercial experience that adds significant bandwidth to Hikma’s ability to maximise its portfolio. He holds a chemical engineering with industrial studies degree from the University of Bradford and has completed multiple senior executive development programmes through world-class business schools. Hikma has also appointed Samuel Park as global head of intellectual property and general counsel for the US.

Evestment

Evestment, a global leader in institutional investor data and analytics, has named Ashish Aryal as head of strategy for EMEA. He will be based in Evestment’s London office. Ashish is responsible for developing and implementing strategic initiatives aimed at furthering Evestment’s growth in the EMEA region. Prior to joining Evestment, Ashish served for seven years as vice president of global market intelligence and corporate strategy at investment giant BlackRock. He has also previously held positions with investment banks Jefferies International and Societe Generale.

Nucleus

Nucleus, the adviser-built wrap, has hired Jeannie Bowman as its inaugural head of internal systems. In this new role Jeannie will be responsible for designing, developing and cultivating the systems at Nucleus, and leading the infrastructure and systems security teams. As well as having accountability for defining and overseeing the development of the IT systems architecture, she will also manage the change associated with all system improvements. Jeannie joins Nucleus from Shell, where she undertook several global IT management projects and operations, in addition to audit management roles. She has 17 years’ experience in the energy industry in a variety of IT related roles and has previously worked internationally as a regional senior IT technical consultant in Kuala Lumpur. Jeannie will report into chief technology officer Andrew Smith.

Morning Wire

Francesca Washtell, editor of City Moves since January 2017, will be leaving Morning Wire to take a role as City reporter at the Daily Mail. She previously served as vice reporter, industrials reporter, diarist, deputy night editor and City Pages editor/book hoarder.

[custom id="162"]

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Personal Development

Related Topics

  • City Moves
  • Company
  • Hikma Pharmaceuticals

Trending Articles

  • Grandparents fund university degrees to avoid inheritance tax net

  • Revolut chatbot goes rogue by charging users to cancel subscription

  • Brompton Bicycle sues former adviser for ‘professional negligence’

  • Revolut takes flight with launch of new airport lounges

  • Is the Zeekr 9X Super Hybrid the new luxury SUV to beat?

More from Morning Wire

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

    Business Wire
  • Promega Achieves 100% Renewable Electricity Across Global Operations

    Business Wire
  • CoStar Data Shows London Dominates UK Office Development as Regional Pipeline Hits 20-Year Low

    Business Wire
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Wenger rubbishes Infantino sell-off plan as senior Fifa figures desert president

    Sport Business
    Arsène Wenger, FIFAs Chief of Global Football Development, in a suit and tie, looking serious.
  • Agilent Increases Its Investment in HALO X-ray Technologies

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook